L atex allergy has been recognized as a health problem since the early 1980s. Health problems associated with the increased use of latex gloves in health care and other occupational settings are increasingly reported by employees (Hunt, 1995; Kelly, 1994; Sussman, 1996) . This problem is of special concern to the occupational health care professional because of its increased prevalence and the importance of work environment modific ation to reduce exposure. Occupations affected include health care, resear ch, food preparation, labor atory, and the latex industry (Sussman , 1991; Tarlo, 1990; Yassin, 1994) . Clinical presentation can vary from simple irritant dermatit is to life threatening anaphylactic shock. The effect of the problem on the emplo yee likewise ranges from relatively minor irritation to threat of loss of occupation and/or life. An understanding of the etiolog y and clinical presentation of latex reaction s will assist in rapid diagnosis and management , therefore reducing the risk of sensitivity, decreased productivity, and perhap s the need for vocational rehabilitation among these workers.
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WHAT IS LATEX SENSITIVITY?
The term "latex sensitivity" often is used to refer to any of the three types of reactions associated with latex exposure. The most common clinical presentation is nonallergic, irritant dermatitis of the hands caused by mechanical and chemical irritation such as the rubber additives in latex gloves (Fay, 1991) . The most frequent allergic reaction is allergic contact dermatitis (ACD) caused by sensitivity to chemical additives in latex products (Heese, 1991) . The least frequent, but most serious reaction is an immediate, systemic, IgE mediated hypersensitivity reaction caused by allergy to the latex proteins (Sussman, 1991) . Clinical presentations characteristic of the types of reactions are summarized in Table 1 . limited to the area of glove contact. This contact dermatitis is a non-allergic skin rash resulting from irritation and breakdown of the skin caused by prolonged direct contact with irritants . Chemical irritants may include antimicrobials or disinfectants left on the skin after hand washing and various chemical additives from the glove manufacturing process. Mechanical irritation results from the rubbing of the glove and powders against the skin and from sweating of the hand under the glove, combined with frequent hand washing and scrubbing of the hands (Shoup, 1995) . The dermatitis caused by this contact irritation may result in subcutaneous/dermal exposure to antigens that may lead to chemical or latex sensitivities in the susceptible individual (Truscott, 1995) . Persistent irritant dermatitis and continued occlusion with glove use may lead to maceration of the skin that mimics allergy to the latex protein (Fay, 1991; Heese, 1991) .
All persons are susceptible to irritant reactions . Therefore, when large groups of workers suddenly present with a dermatitis, the cause is most likely irritation rather than allergy. Obtaining information about hand washing and rinsing technique is helpful. The length of time wearing gloves with associated hyper-hydration also is a risk factor for injury. The occlusion and increased moisture associated with glove use breaks down the outer, protective epidermal layer of the skin, creating potentially sensitizing conditions (Gonzales, 1992; Hamman, 1993) .
Allergic Contact Dermatitis
ACD is characterized by localized redness, clustered vesicles, swelling, itching, cracking, eczema, and fingertip fissures. Features of the chronic condition include hyperplasia, desiccation , crusting , papule formation, scaling, and peeling with open lesions. Although the reaction may extend up the arm, it is not systemic and there is low risk for anaphylaxis. Symptom onset is delayed, usually appearing within 6 to 48 hours of exposure (Shoup, 1995) . This reaction sometimes is referred to as delayed type hypersensitivity or Type IV allergic reaction (McCormack, 1995; Sussman, 1995) .
A history of allergies predisposes the individual to allergic contact dermatitis reactions . Some persons may become sensitized to the chemicals used in the manufacture of latex which remain in the gloves (or other latex devices). Allergic reactions result from prolonged contact with these chemicals in gloves. Chemical accelerators used in the latex manufacturing process account for most of these allergic reactions, with thiurams responsible for 72% of all occupation related dermal allergies 84 (Hamman, 1993) . The inflammatory response often makes it difficult to distinguish an irritant from an allergic contact dermatitis.
Immediate Systemic/Anaphylaxis Reactions
The most serious type of reaction is an immediate IgE mediated allergic response to the latex proteins themselves-the Type I, immediate reaction-usually occurring within 5 to 30 minutes of latex exposure. The clinical presentation can be a severe, generalized skin reaction, upper respiratory symptoms, or life threatening anaphylaxis reaction. Signs and symptoms may include: • Edema and itching around the eyes. • Rhinitis.
• Nasal itching and sneezing. • Urticaria. • Dermatitis. • Shortness of breath. • Asthma, airway obstruction due to bronchospasm . • Sudden drop in blood pressure, which may progress to anaphylactic shock (Charous, 1994; Hamann, 1993; Shoup, 1995) . The generalized IgE mediated response is initiated by direct contact with latex on non-intact skin, resulting in sensitization before manifesting as a generalized reaction. A breakdown of the natural skin barrier, as with contact dermatitis, may be involved in latex sensitization. The degree of exposure and length of time needed is unknown (Slater, 1992) . Once sensitized, progression may occur from localized (hand) to generalized (anaphylactic) allergic responses (Sussman, 1995) . The progression can be insidious , beginning with mild contact itching or rash, then progress to contact urticaria on to anaphylaxis without warning. Once sensitivity has been initiated, any contact with latex may cause a recurrence of the reaction whether the contact is to latex gloves in the dentist's chair, blowing up balloons , or using latex condoms (Hunt, 1995) . Not all individuals with latex protein allergies present with serious systemic symptoms. With more sensitive serum tests, it is now possible to identify latex specific IgE antibodies in individuals with dermal, but without systemic symptoms.
Exposure to latex proteins on airborne glove powder or other aerosols can result in a recurrence of the symptoms in the sensitized person. Direct contact of the mucous membranes or dermal layer with latex products is not needed to cause symptoms (Lagier, 1992) . This is important because a sensitized employee using non-latex gloves in an area where coworkers are using powdered latex gloves may continue to get exposure through the airborne, as well as direct contact routes (Beezhold, 1992 , Heilman, 1996 . Latex becomes aerosolized when gloves are snapped while putting on and off. Examples of direct contact include touching telephones, computer keyboards, and other work surfaces with protein containing powder on them. Significant lifestyle changes, including a change of occupation, may be needed to protect the sensitized individual if exposures from coworkers in the work environment are not controlled .
RISK FACTORS FOR LATEX SENSITIVITY
Risk for sensitization varies with the susceptibility of the individual. Not all persons with latex protein allergies develop the immediate systemic symptoms, and not all persons with latex exposure develop latex allergy. Identified risk groups include clients with spina bifida and congenital genitourinary abnormalities (requiring frequent catheterizations), health care workers (including housekeepers, lab workers, dentists, nurses, physicians), rubber industry workers, atopic persons such as those with asthma, rhinitis, and eczema, and persons with history of multiple surgical procedures (Sussman, 1996) .
The prevalence of latex allergy in children with spina bifida ranges from 28% to 67% (Sussman, 1995) . It is believed that mucosal absorption of latex during multiple surgical procedures done early in life may sensitize these children. Results of a study by Konz (1995) suggest that, in addition to the increased latex exposure, there may be altered neuroimmunologic interactions in the spina bifida population.
Health care workers who have regular latex exposure by wearing latex gloves or by inhaling aerosolized latex in the workplace also have been shown to be at increased risk, with prevalence of 3% to 17% (Sussman , 1995) . In a study of workers in a surgical glove manufacturing plant, 11% were found to have positive skin test responses (Tarlo, 1990) . The frequency of clinical reactions to latex in workers with intermittent exposure to latex, such as police officers, ambulance attendants, funeral home workers, fire fighters, food/restaurant workers, painters, and gardeners, has not been determined.
Persons with atopic symptoms such as asthma , rhinitis, or eczema and individuals with certain food allergies have a higher risk for latex sensitivity. Foods such as banana , avocado , chestnut, apricot, kiwi, papaya, passion fruit, pineapple, peach, nectarine, plum, cherry, melon, fig, grape, potato, tomato, and celery also may be associated with latex sensitivity (Sussman, 1996) . The prevalence of anti-latex IgE antibodies in a study of 1000 volunteer blood donors was 6.4%, higher than previous estimates have suggested (Ownby, 1996) . 
IDENTIFICATION AND MANAGEMENT OF LATEX REACTIONS
The two major goals in the management of latex reactions are successful identification and treatment of all dermatitis to prevent future sensitization, and identification of latex allergy to prevent serious, life threatening sequelae whenever possible. Guidelines from the American Academy of Allergy and Immunology (AAAI, 1993) and the American College of Asthma, Allergy and Immunology (ACAAI) (Sussman, 1996) recommend that clients with hand dermatitis and exposure to latex need to be evaluated with a health history review and clinical testing.
Health History
A focused health history is necessary to identify risk factors, current symptoms, and problems related to latex exposure . In 1991, the FDA advised all health care workers to include questions about latex sensitivity when taking a health history. Focus of the history is documenting all reactions to latex: medical, surgical, dental, and household products such as gloves, clothing, contraceptive devices, or toys. Identification of allergic reactions such as contact dermatitis, urticaria, angioedema, rhinitis, conjunctivitis, asthma, and anaphylaxis is important. Attention is given to identifying and describing unexplained intraoperative events, a history of multiple surgical procedures, reactions to latex cross reacting foods, and the presence or history of documented atopic disorders including asthma, rhinitis, and eczema.
The ACAAI developed a recommended history questionnaire (Sussman, 1996) . Table 2 is a sample history questionnaire to assist in the evaluation of rashes and possible latex reactions .
Clinical Evaluation
The health history and clinical presentation are not sufficient to diagnose persons with sensitivity to latex chemicals or proteins. Clinical evaluation includes testing to identify allergy both to the chemical additives and to latex proteins. According to the most recent guidelines of the ACAAI, all persons with hand dermatitis and exposure to latex need to be referred for consultation to determine and document sensitivities to rubber additives and determination of IgE antibodies to latex proteins. Diagnostic methods may include a variety of methods.
Skin patch testing is used for identification of allergens in allergic contact dermatitis, but not irritant contact dermatitis. Immunogenic rubber additive chemicals in appropriate concentration are taped on the client's back for 48 to 96 hours. Patch tests are performed and interpreted according to standardized techniques (Sussman, 1996) . shown to be positively related to clinical manifestations (Hadj iliadis, 1996) . Skin prick testing with latex extract must be done by a qualified specialist with resuscitative equipment and medication available to manage anaphylactic reactions (Kelly, 1994) .
IgE antibody immunoassays are used to measure IgE antibody in serum. Assay method s curre ntly used include the enzyme linked immunosorbent assay (ELISA), the radioallergosorbent test (RAST) and Immunocap System, and the latex AlaSTAT. Clinical tests such as the AlaSTAT have increased the diagnostic sensitivity to 96% compared with skin testing (McCullough, 1993) .
"Use tests" may be done in the case of a negative serologic test result and a compelling history. A finger tip is cut from a latex surgical glove, dampened with water, and placed on one finger for 15 minutes. Urticaria with itching or erythema indicates a positive result. If no reaction ensues, an entire wet latex glove is placed on the hand for 15 minutes or until a positive reaction occurs. A compelling history and a positive serologic test result eliminate the need for "use" skin testing (Kelly, 1994) .
Although the presence of latex-specific IgE antibody can be detected by skin and serum tests, they do not necessarily predict clinical symptoms or problems (Kelly, 1994) . Also, a negative latex specific IgE test does not rule out a latex allergy. The ACAAI guidelines recommend all individuals with a positive latex skin or serological test follow latex avoidance precautions (Sussman, 1996) .
CLINICAL MANAGEMENT OF IRRITANT CONTACT DERMATITIS
The treatment goal of irritant contact dermatitis is to promote healing of the current dermatitis, prevent recurrence, and avoid contact with latex proteins on broken skin. Focus is on reducing irritants, especially glove powder, frequent hand washing, and use of antimicrobials directly on skin. • Apply topical steroids to reduce the inflammatory response.
• Use hydrating creams after water contact and overnight with cotton gloves to keep in place. Hydrocarbon or petroleum lotions or creams should not be used directly with latex gloves due to breakdown of the latex. • Use cotton glove liners during glove use to decrease moisture and mechanical irritation of glove and powders. • Eliminate unnecessary glove use and remove gloves frequently to prevent hyper-hydration and the adverse effects of excessive occlusion. • Avoid barrier creams that promote the release of latex proteins from latex gloves. • Try non-powdered gloves or change to a different glove type or another manufacturer. • Increase air circulation and decrease friction on the skin by using a glove in a larger size than usual. • Follow effective hand washing technique. Use tepid water and do not apply disinfectant soap or harsh chemicals to dry hands. To ensure the removal of soaps and disinfectants, remove jewelry to rinse hands thoroughly. • Advise client regarding prevention of bloodborne 88 pathogen exposure and other infectious agent exposure. When necessary, to allow the skin to heal, consider alternate temporary assignment that does not require glove use.
• Evaluate for latex allergy as indicated.
• Consider diagnosis of allergic contact dermatitis and refer to dermatologist or allergist familiar with glove reactions if problem persists.
CLINICAL MANAGEMENT OF ALLERGIC CONTACT DERMATITIS
The treatment goal of ACD, Type IV hypersensitivity, is to identify chemical additives in gloves as the source of the allergy in order to heal the dermatitis and prevent future exposures. Additionally, it is important to decrease the risk of latex allergy by preventingbroken skin contact with latex proteins. To distinguish the ACD from irritant dermatitis, it is useful to ask "How long after return to work from vacation (or other prolonged time away from glove use) does it take before your hands start to bother you?" With ACD, the response is delayed 6 to 48 hours. It is especially important to rule out inadequate rinsing of hands after washing or the use of disinfectants as the cause.
The strategies described above for management of irritant dermatitis are also useful for ACD. In addition, it is important to consider the following: • Trial gloves low in contact sensitivity, low allergen/antigen, minimal extractable accelerators, antioxidants, or other chemicals 
CLINICAL MANAGEMENT OF SYSTEMICIIMMEDIATE ALLERGY
The goals of clinical management for persons with systemic latex allergy are to eliminate latex exposure whenever possible and instruct in measures to treat symptoms. Workers with symptomatic latex allergy often present with severe allergic rhino conjunctivitis and asthma interfering with their ability to work.
Reducing Latex Exposure in the Work Environment
To eliminate or reduce the risk for latex sensitization of asymptomatic staff and minimize the risk of latex exposure to staff already sensitized :
• Eliminate unnecessary use of latex gloves by providing workers with non-latex gloves when there is minimal potential for contact with blood or bodily fluids . For example , housekeeping, food service, or facilities service workers often wear latex gloves which can be substituted with more appropr iate types of gloves. Food prepared for persons with latex allergy must not be handled by workers wear ing latex gloves.
• When selecting a latex glove for barrier protection from infectious materials, choose a reduced protein , powder free glove (NIOSH , 1997).
• Identify the areas of high risk. Index latex products and where they are used. Identify areas of high volume use of latex gloves from information which may be obtained from purchasing records or user surveys .
• Provide education to employees about latex allergies, hand care, and the importance of early care for dermatitis or other allergy symptoms. Identify and instruct workers in work practices to prevent exposure. For example, workers need to remove gloves and wash hands before charting, using computers, and telephones.
• Implement a latex allergy assessment protocol , including a screening history questionnaire and protocol for evaluation and treatment of latex reaction symptoms. Identify specialists familiar with latex reactions and allergy for consu ltation and referrals. Include latex allergy screen ing questions and clinical evaluation of symptomatic individuals in preplacement health evaluations.
• Conduct analys is to identify trends in reports of latex related reactions. Establish definitions for latex illnesses codes for consistent records.
• Educate employees about the signs and symptoms of possible latex allergy. Encourage the reporting of these symptoms to the Occupational Health Service .
• Establish criteria for and use of a standard approach for latex allergy assessment.
• Develop a mechanism to instruct individuals at risk due to atopy, exposure, or other risk factors about how to minimize potential sensitization.
• Conduct a works ite evaluation to assess the role the ventilation system may play in dispersing aerosolized latex proteins. Glove powder and laundry lint have clogged filters in work areas resulting in decreased air exchanges and an increase in allergens in indoor air. Increase the frequency of filter changing/cleaning as indicated.
• Evaluate the work environments of latex sensitized employees to determine the ability to provide accommodations for a latex safe environment. The ACAAI gUidelines recommend "Non-powdered, low prote in gloves should be the standard in a health care facility. Non-latex gloves need to be evaluated with regard to durability, barrier protection and cost for the intended use" (Sussman , 1996) .
Another group of persons identified as allergic to latex proteins may have experien ced irritant or allergic dermatitis, however, they do not report systemic symptoms. Skin testing and clinical tests such as the AlaS-TAT test detect the presence of a latex specific IgE antibody in the skin and serum respectively, and do not necessarily predict clinical presentati ons such as anaphylaxis (Kelly, 1994) . The ACAAI Guidel ines (Sussman, 1996) • Avoiding contact with others and objects such as computer keyboards or telephone s that have been in contact with latex gloves/glove powder.
• Communicating work accommodations to coworkers • Keeping an epinephrine self injection kit available such as Epi-Pen or AnaKit to use in case of systemic latex allergic reactions (See Resources).
RESOURCES
• Advising clients that although progression of symptoms is not predictable, there is risk of increasing allergic reactions with continued exposures to high levels of latex allergens.
• Advising clients about eating foods known to cross react with latex sensitivities.
• Carrying non-latex substitutes for gloves or other necessary health care supplies by latex allergic individuals, as non-latex substitutes may not be available at all health care facilities. All dental and other health care procedures must be performed with non-latex gloves. Clients must be cautioned against contact with other latex products such as condom s and rubber dental dams (Tarlo, 1994) .
Recommendations to reduce latex exposure in the work environment are described in the Box on page 89.
CONCLUSION
Allergy to latex is a rapidly emerging occupational and environmental health problem . Measures to prevent the transmission of bloodbome diseases have inadvertently resulted in exposure to latex proteins and chemical sensitizers. The implementation of universal precautions in 1987 to prevent HIV and other bloodbome pathogen infections resulted in an increased demand for gloves. Manufacturing processes may have temporarily changed to meet this dramatically increased demand for gloves, resulting in latex products with higher allergic and/or irritant properties being produced and used (Hamman, 1994; McCormack, 1995) . The increased use of condoms by those at risk for contracting HIV infection has further exposed the population to latex (Gonzalez, 1992) . In addition, increased awareness of the problem may have resulted in increased recognition and reporting of this allergy in the past several years (Kelly, 1994) .
Options for low allergen, powder free latex and latex free synthetic gloves are increasingly available. Glove manufacturers are working to lower protein levels and chemicals such as thiurams that account for 80% of all Type IV chemical sensitivity reactions in allergic contact dermatitis. Assays are available to evaluate the variability of extractable latex allergen and protein levels in gloves . These efforts, along with the work practice recommendations described above, will reduce the risk of new sensitization and severe systemic allergic reactions. Occupational and environmental health professionals can effectively manage latex/glove reactions by identifying appropriate treatment plans, selecting and using powder free and latex free gloves, and, whenever possible, implementing work practices to minimize latex protein in the work environment.
The increased use of natural rubber latex barrier protection to prevent exposure to bloodborne pathogens has led to an increase in latex related health reactions, particularly associated with glove use.
The three types of reactions to latex in order of frequency include irritant contact dermatitis, allergic contact dermatitis, and immediate systemic/anaphylaxis reactions.
The management goal for all reactions is to avoid unnecessary restriction from the appropriate use of latex (gloves) which provides the best barrier protection, while protecting individual workers from exposure that results in sensitization or causes sensitized individuals to have serious reactions.
Choose non-latex gloves when barrier protection from bloodborne pathogens is not an issue. When selecting a latex glove, choose a glove that is low in proteins and powder free to control airborne latex exposure.
received a negative serologic test result. The nurse counsels the employee that the next test administered will probably be: A. Skin patch testing. B. Skin prick testing. C. "Use" skin testing.
D. ELISA.
8. The nurse is most likely to recommend which of the following in the clinical management of an employee with irritant contact dermatitis of the hands? A. Using a hydrocarbon lotion when wearing latex gloves. B. Using cotton glove liners during glove use. C. Applying antimicrobial cream to hands. D. Wearing a medical alert bracelet to indicate allergy.
9. Serology testing reveals that an employee has latex-specific IgE antibodies. The clinical management of this employee includes teaching to: A. Avoid contact with others and objects that have been in contact with latex gloves. B. Use low protein/allergen latex gloves. C. Avoid foods such as apples , aged cheeses, and red wine. D. Use glovelinersunderlatexgloves.
10. An nurse is developing a comprehensive program to reduce latex exposure in the work environment. To obtain the resource, "Nursing Council Guidelines for Establishing Latex Allergy Precautions," the nurse should contact the: A. American College of Allergy, Asthma, and Immunology. B. American Nurses Association. C. American Association of Nurse Anesthetists. D. Spina Bifida Association of America.
